How are we addressing axial psoriatic arthritis in clinical practice?

dc.contributor.author	Michelena, Xabier
dc.contributor.author	López Medina, Clementina
dc.contributor.author	De Miguel, Eugenio
dc.contributor.author	Moreno Ramos, Manuel José
dc.contributor.author	Queiro Silva, Rubén
dc.contributor.author	Marzo Ortega, Helena
dc.contributor.author	Juanola, Xavier
dc.date.accessioned	2025-03-14T08:51:14Z
dc.date.available	2025-03-14T08:51:14Z
dc.date.issued	2024
dc.identifier.citation	Rheumatology and Therapy (2024); doi:10.1007/s40744-024-00722-w
dc.identifier.issn	2198-6576
dc.identifier.issn	2198-6584
dc.identifier.uri	https://hdl.handle.net/10651/77638
dc.description.sponsorship	Novartis Farmaceutica S.A., Spain; National Institute for Health Research (NIHR) Leeds Biomedical Research Centre (LBRC)
dc.language.iso	eng
dc.relation.ispartof	Rheumatology and Therapy
dc.rights	©,
dc.source	WOS:001335349000001
dc.title	How are we addressing axial psoriatic arthritis in clinical practice?
dc.type	journal article
dc.identifier.doi	10.1007/s40744-024-00722-w
dc.relation.publisherversion	http://dx.doi.org/10.1007/s40744-024-00722-w

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.